Follow
Ryan D Mellor
Ryan D Mellor
School of Pharmacy, University College London (UCL)
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
K Pyrć, A Milewska, EB Duran, P Botwina, A Dabrowska, M Jedrysik, ...
Scientific reports 11 (1), 20012, 2021
472021
Ultrasmall-in-nano: why size matters
RD Mellor, IF Uchegbu
Nanomaterials 12 (14), 2476, 2022
172022
Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure
S Dimiou, RM Lopes, I Kubajewska, RD Mellor, CS Schlosser, MS Shet, ...
International journal of pharmaceutics 618, 121658, 2022
82022
Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters
RD Mellor, AG Schätzlein, IF Uchegbu
Nanomaterials 11 (9), 2181, 2021
32021
Development of bio-functionalized, Raman responsive, excretable gold nanoclusters
RD Mellor
UCL (University College London), 2023
2023
Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents—A Novel Polymer Formulation for Anticancer Therapy
Y Lerchbammer-Kreith, M Hejl, NS Sommerfeld, X Weng-Jiang, U Odunze, ...
Pharmaceuticals 16 (7), 1027, 2023
2023
Amphiphilic carbohydrate compounds
R Mellor
US Patent App. 17/926,772, 2023
2023
Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters. Nanomaterials 2021, 11, 2181
RD Mellor, AG Schätzlein, IF Uchegbu
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–8